Chemistry:Miriplatin

From HandWiki

Miriplatin (INN; trade name Miripla) is a drug used to treat hepatocellular carcinoma (HCC). It is a lipophilic platinum complex that is used in transcatheter arterial chemoembolization (TACE).[1][2] Miriplatin was approved by Japan's Pharmaceuticals and Medical Devices Agency in 2009.[1]

See also

References

  1. ↑ 1.0 1.1 "Miriplatin". Inxight Drugs. National Center for Advancing Translational Sciences, National Institutes of Health. https://drugs.ncats.io/substance/780F0P8N4I. 
  2. ↑ "Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial". Journal of Gastroenterology 53 (2): 281–290. February 2018. doi:10.1007/s00535-017-1374-6. PMID 28766016. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Miriplatin&oldid=4028840"